| Pharmaceutical Information |
| Drug Name |
Mepenzolate bromide |
| Drug ID |
BADD_D01383 |
| Description |
Mepenzolate is a post-ganglionic parasympathetic inhibitor. It decreases gastric acid and pepsin secretion and suppresses spontaneous contractions of the colon. Mepenzolate diminishes gastric acid and pepsin secretion. Mepenzolate also suppresses spontaneous contractions of the colon. Pharmacologically, it is a post-ganglionic parasympathetic inhibitor. It has not been shown to be effective in contributing to the healing of peptic ulcer, decreasing the rate of recurrence, or preventing complications. |
| Indications and Usage |
Not Available |
| Marketing Status |
Discontinued |
| ATC Code |
A03AB12 |
| DrugBank ID |
DB04843
|
| KEGG ID |
D00720
|
| MeSH ID |
C005101
|
| PubChem ID |
6461
|
| TTD Drug ID |
D0FV3V
|
| NDC Product Code |
Not Available |
| Synonyms |
mepenzolic acid | mepenzolate iodide | mepenzolate bromide | mepenzolic acid, bromine salt | N-methyl-3-piperidylbenzilate methyl bromide | mepenzolate | Cantil | mepenzolate bromide, (+-)-isomer | mepenzolic acid, bromine salt, 1-(methyl-(14)C)-labeled |
|
| Chemical Information |
| Molecular Formula |
C21H26BrNO3 |
| CAS Registry Number |
76-90-4 |
| SMILES |
C[N+]1(CCCC(C1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C.[Br-] |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
